FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...